This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2021 Oct 16;398(10309):1386-1388.

doi: 10.1016/S0140-6736(21)02002-X. Epub 2021 Sep 22.

The changing landscape of chlamydia control strategies

Nicola Low¹, Jane S Hocking², Jan van Bergen³

Affiliations

Affiliations

¹ Institute of Social and Preventive Medicine, University of Bern, Bern CH-3012, Switzerland. Electronic address: nicola.low@ispm.unibe.ch.
² Melbourne School of Population and Global Health, University of Melbourne, Melbourne, VIC, Australia.
³ SOA AIDS Netherlands, Amsterdam, Netherlands; Department of General Practice/Family Medicine, Amsterdam University Medical Center, Amsterdam, Netherlands.

PMID: 34562393
DOI: 10.1016/S0140-6736(21)02002-X

Comment

The changing landscape of chlamydia control strategies

Nicola Low et al. Lancet. 2021.

. 2021 Oct 16;398(10309):1386-1388.

doi: 10.1016/S0140-6736(21)02002-X. Epub 2021 Sep 22.

Authors

Nicola Low¹, Jane S Hocking², Jan van Bergen³

Affiliations

¹ Institute of Social and Preventive Medicine, University of Bern, Bern CH-3012, Switzerland. Electronic address: nicola.low@ispm.unibe.ch.
² Melbourne School of Population and Global Health, University of Melbourne, Melbourne, VIC, Australia.
³ SOA AIDS Netherlands, Amsterdam, Netherlands; Department of General Practice/Family Medicine, Amsterdam University Medical Center, Amsterdam, Netherlands.

PMID: 34562393
DOI: 10.1016/S0140-6736(21)02002-X

No abstract available

PubMed Disclaimer

Comment on

Population effectiveness of opportunistic chlamydia testing in primary care in Australia: a cluster-randomised controlled trial.
Hocking JS, Temple-Smith M, Guy R, Donovan B, Braat S, Law M, Gunn J, Regan D, Vaisey A, Bulfone L, Kaldor J, Fairley CK, Low N; ACCEPt Consortium. Hocking JS, et al. Lancet. 2018 Oct 20;392(10156):1413-1422. doi: 10.1016/S0140-6736(18)31816-6. Lancet. 2018. PMID: 30343857 Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information